We are live on ! Find out more
ACIU icon

AC Immune

42 hedge funds and large institutions have $81.2M invested in AC Immune in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

841% more call options, than puts

Call options by funds: $1.12M | Put options by funds: $119K

207% more capital inflows, than outflows

Capital inflows: $5.52M | Capital outflows: $1.8M

50% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 10

5% more funds holding

Funds holding: 40 → 42 (+2)

1.25% more ownership

Funds ownership: 24.52% → 25.77% (+1.2%)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

Holders
42
Holders Change
+2
Holders Change %
+5%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
10
Closed
6
Calls
$1.12​M
Puts
$119​K
Net Calls
+$1​M
Net Calls Change
+$795​K

ACIU Hedge Fund Activity: Q4 2025 in Review

42 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2025, worth a combined $81.2M — up 14% from $71.1M a quarter earlier.

Fund positioning in ACIU was balanced in Q4 2025: 6 funds opened new positions, 6 closed out, 15 added to existing stakes and 10 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $1.21M. The largest seller was Deutsche Bank, exiting entirely with an estimated $732K sold.

  • 42 institutional investors held AC Immune (ACIU) as of Q4 2025, up from 40 in Q3 2025.
  • Funds reported $81.2M of AC Immune stock for Q4 2025, up 14% quarter-over-quarter.
  • 6 funds opened new AC Immune positions in Q4 2025 and 6 closed out, a net change of 0 holders.
  • The largest AC Immune buyer in Q4 2025 was Point72 Asset Management, an estimated $1.21M added.
  • The largest AC Immune seller in Q4 2025 was Deutsche Bank, an estimated $732K sold.

Based on aggregated 13F filings for Q4 2025.